Cargando…
Antiphospholipid antibodies in COVID-19: a meta-analysis and systematic review
BACKGROUND: Many studies reported high prevalence of antiphospholipid antibodies (aPL) in patients with COVID-19 raising questions about its true prevalence and its clinical impact on the disease course. METHODS: We conducted a meta-analysis and a systematic review to examine the prevalence of aPL a...
Autores principales: | Taha, Muhanad, Samavati, Lobelia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8103564/ https://www.ncbi.nlm.nih.gov/pubmed/33958439 http://dx.doi.org/10.1136/rmdopen-2021-001580 |
Ejemplares similares
-
Sarcoidosis and neuroendocrine tumours: case report and literature review
por: Taha, Muhanad, et al.
Publicado: (2021) -
Incidence and risk factors of COVID-19 associated pneumothorax
por: Taha, Muhanad, et al.
Publicado: (2022) -
Coronavirus Disease 2019 in Immunocompromised Organ Transplant Recipients: A Case Report and Review of the Literature
por: Taha, Muhanad, et al.
Publicado: (2020) -
Forty-One-Year-Old Man with Pulmonary Embolism 5 Months After
COVID-19
por: Taha, Muhanad, et al.
Publicado: (2021) -
ACE2, Much More Than Just a Receptor for SARS-COV-2
por: Samavati, Lobelia, et al.
Publicado: (2020)